Tempus listed on the NASDAQ stock exchange, providing diagnostic data and AI tools to facilitate drug approval processes.
Steady: 0 in the last 7 days
Updated nov 6
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Tempus listed on the NASDAQ stock exchange, providing diagnostic data and AI tools to facilitate drug approval processes.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Tempus AI is listed on Nasdaq and is competing for investment with Alignment Healthcare.1 source
Cantor Fitzgerald initiated coverage on Tempus AI shares, which is listed on Nasdaq.1 source
- Tempus listed on Nasdaq, filed disclosures with the SEC, and received research reports from Jefferies Financial Group.Sub-event
Tempus IPO on NASDAQ highlights its role in AI diagnostics and drug approval.1 source
Keep exploring
The entities involved
Coverage
Newest first; wire copies grouped- dailypolitical.com
- themarketsdaily.com
- themarketsdaily.com
- yahoo.com
- insidermonkey.com
- insidermonkey.com